Coffee Intake in Midlife and Risk of Dementia and its Neuropathologic Correlates
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
While animal data suggest a protective effect of caffeine on cognition, studies in humans remain inconsistent. We examined associations of coffee and caffeine intake in midlife with risk of dementia, its neuropathologic correlates, and cognitive impairment among 3494 men in the Honolulu-Asia Aging Study (mean age 52 at cohort entry, 1965-1968) examined for dementia in 1991-1993, including 418 decedents (1992-2004) who underwent brain autopsy. Caffeine intake was determined according to self-reported coffee, tea, and cola consumption at baseline. Logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for overall dementia, Alzheimer's disease (AD), vascular dementia (VaD), cognitive impairment (Cognitive Abilities Screening Instrument score <74), and neuropathologic lesions at death (Alzheimer lesions, microvascular ischemic lesions, cortical Lewy bodies, hippocampal sclerosis, generalized atrophy), according to coffee and caffeine intake. Dementia was diagnosed in 226 men (including 118 AD, 80 VaD), and cognitive impairment in 347. There were no significant associations between coffee or caffeine intake and risk of cognitive impairment, overall dementia, AD, VaD, or moderate/high levels of the individual neuropathologic lesion types. However, men in the highest quartile of caffeine intake (>/=411.0 mg/d) [corrected] were less likely than men in the lowest quartile (</=137.0 mg) [corrected] to have any of the lesion types (adjusted-OR, 0.45; 95% CI, 0.23-0.89; p, trend = 0.04). Coffee and caffeine intake in midlife were not associated with cognitive impairment, dementia, or individual neuropathologic lesions, although higher caffeine intake was associated with a lower odds of having any of the lesion types at autopsy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The remaining cohort studies (3 of 11, 27%) did not find an association between caffeine intake and cognitive change [161] or incident dementia [166,174].”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [174]
In the citing paper
“Finally, large cohort studies of men and women have also found an inverse relationship between caffeine consumption and the risk of Parkinson’s disease (90–92) and Alzheimer’s disease (93–95).”
From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [95]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 1×
“receptor antagonist, acts as a brain stimulant acutely 324 and enhances alertness [21].”
BackgroundThe Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,374
Chui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201
Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised
Kobylski, T. P. (1988) · Psychosomatics · doi:10.1016/s0033-3182(88)72438-x · Cited by 1,054
Teng, E. L., Hasegawa, K., Homma, A., Imai, Y., Larson, E., Graves, A., Sugimoto, K., Yamaguchi, T., Sasaki, H., Chiu, D., et al. (1994) · International Psychogeriatrics · doi:10.1017/s1041610294001602 · Cited by 926
Self-citationAssociation of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Self-citationWalking and Dementia in Physically Capable Elderly Men
Abbott, R. D. (2004) · JAMA · doi:10.1001/jama.292.12.1447 · Cited by 743 · cited 1×
“This corresponds approximately to a score of 22 on the Mini-Mental State Examination, a level often used to indicate cognitive impairment [13].”
Self-citationArendash, G. W., Schleif, W., Rezai-Zadeh, K., Jackson, E. K., Zacharia, L. C., Cracchiolo, J. R., Shippy, D., & Tan, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.021 · Cited by 457
Cited by
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
“The remaining cohort studies (3 of 11, 27%) did not find an association between caffeine intake and cognitive change [161] or incident dementia [166,174].”
BackgroundThe Safety of Ingested Caffeine: A Comprehensive Review
Temple, J. L., Bernard, C., Lipshultz, S. E., Czachor, J. D., Westphal, J. A., & Mestre, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00080 · Cited by 557
The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
McGeer, P. L., & McGeer, E. G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1177-7 · Cited by 467
How does adenosine control neuronal dysfunction and neurodegeneration?
Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 441
Dominguez, L. J., Veronese, N., Vernuccio, L., Catanese, G., Inzerillo, F., Salemi, G., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13114080 · Cited by 433
Hersi, M., Irvine, B., Gupta, P., Gomes, J., Birkett, N., & Krewski, D. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.006 · Cited by 332
The impact of coffee on health
Cano-Marquina, A., Tarín, J. J., & Cano, A. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.02.002 · Cited by 321
Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
Jiang, T., Yu, J.-T., Tian, Y., & Tan, L. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990155 · Cited by 225
Nutrition and cognitive health: A life course approach
Puri, S., Shaheen, M., & Grover, B. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1023907 · Cited by 224
Caffeine Consumption through Coffee: Content in the Beverage, Metabolism, Health Benefits and Risks
dePaula, J., & Farah, A. (2019) · Beverages · doi:10.3390/beverages5020037 · Cited by 222
Rivera-Oliver, M., & Díaz-Ríos, M. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.01.083 · Cited by 202
The capillary dysfunction hypothesis of Alzheimer's disease
Østergaard, L., Aamand, R., Gutiérrez-Jiménez, E., Ho, Y.-C. L., Blicher, J. U., Madsen, S. M., Nagenthiraja, K., Dalby, R. B., Drasbek, K. R., Møller, A., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.09.011 · Cited by 199
Panza, F., Solfrizzi, V., Barulli, M. R., Bonfiglio, C., Guerra, V., Osella, A., Seripa, D., Sabbà, C., Pilotto, A., & Logroscino, G. (2015) · The Journal of nutrition, health and aging · doi:10.1007/s12603-014-0563-8 · Cited by 194
Zhang, Y., Yang, H., Li, S., Li, W.-D., & Wang, Y. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003830 · Cited by 194
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
IJzerman, A. P., Jacobson, K. A., Müller, C. E., Cronstein, B. N., & Cunha, R. A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000445 · Cited by 179
Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
Ren, X., & Chen, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.602697 · Cited by 178
Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies
White, L. R., Edland, S. D., Hemmy, L. S., Montine, K. S., Zarow, C., Sonnen, J. A., Uyehara-Lock, J. H., Gelber, R. P., Ross, G. W., Petrovitch, H., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002480 · Cited by 171
Self-citationNutritional prevention of cognitive decline and dementia.
Dominguez, L. J., & Barbagallo, M. (2018) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89i2.7401 · Cited by 166
Matos, M., Augusto, E., Machado, N. J., dos Santos-Rodrigues, A., Cunha, R. A., & Agostinho, P. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120469 · Cited by 130
Espinosa, J., Rocha, A., Nunes, F., Costa, M. S., Schein, V., Kazlauckas, V., Kalinine, E., Souza, D. O., Cunha, R. A., & Porciúncula, L. O. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-111982 · Cited by 143
Alzheimer's disease and diet: a systematic review
Yusufov, M., Weyandt, L. L., & Piryatinsky, I. (2017) · International Journal of Neuroscience · doi:10.3109/00207454.2016.1155572 · Cited by 140
Li, P., Rial, D., Canas, P. M., Yoo, J.-H., Li, W., Zhou, X., Wang, Y., van Westen, G. J. P., Payen, M.-P., Augusto, E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.182 · Cited by 140
Adenosine Receptor Control of Cognition in Normal and Disease
Chen, J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00012-x · Cited by 152
Bhatti, G. K., Reddy, A. P., Reddy, P. H., & Bhatti, J. S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00369 · Cited by 145
González-Latapí, P., Bayram, E., Litvan, I., & Marras, C. (2021) · Behavioral Sciences · doi:10.3390/bs11050074 · Cited by 145
Liu, Q., Wu, Y., Cheng, H., Xia, T., Ding, H., Wang, H., Wang, Z., & Xu, Y. (2016) · Nutrition · doi:10.1016/j.nut.2015.11.015 · Cited by 134
Health benefits of methylxanthines in neurodegenerative diseases
Oñatibia‐Astibia, A., Franco, R., & Martínez‐Pinilla, E. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600670 · Cited by 105
Wu, L., Sun, D., & He, Y. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.05.015 · Cited by 110
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
Libro, R., Giacoppo, S., Soundara Rajan, T., Bramanti, P., & Mazzon, E. (2016) · Molecules · doi:10.3390/molecules21040518 · Cited by 107
Silva, A. C., Lemos, C., Gonçalves, F. Q., Pliássova, A., Machado, N. J., Silva, H. B. L., Canas, P. M., Cunha, R. A., Lopes, J. P., & Agostinho, P. M. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.024 · Cited by 95
Larsson, S. C., & Orsini, N. (2018) · Nutrients · doi:10.3390/nu10101501 · Cited by 94
Coffee intake and decreased amyloid pathology in human brain
Kim, J. W., Byun, M. S., Yi, D., Lee, J. H., Jeon, S. Y., Jung, G., Lee, H. N., Sohn, B. K., Lee, J.-Y., Kim, Y. K., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0604-5 · Cited by 86
Carman, A. J., Dacks, P. A., Lane, R. F., Shineman, D. W., & Fillit, H. M. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0021-7 · Cited by 85
Fukutomi, R., Ohishi, T., Koyama, Y., Pervin, M., Nakamura, Y., & Isemura, M. (2021) · Molecules · doi:10.3390/molecules26020415 · Cited by 82
Lifestyle Factors and Dementia in the Oldest-old: The 90+ Study
Paganini-Hill, A., Kawas, C. H., & Corrada, M. M. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000087 · Cited by 71
Alcohol, coffee and tea intake and the risk of cognitive deficits: a dose–response meta-analysis
Ran, L. S., Liu, W. H., Fang, Y. Y., Xu, S. B., Li, J., Luo, X., Pan, D. J., Wang, M. H., & Wang, W. (2021) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796020001183 · Cited by 69
Caffeine and Cognitive Decline in Elderly Women at High Vascular Risk
Vercambre, M.-N., Berr, C., Ritchie, K., & Kang, J. H. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122371 · Cited by 66
Neuroprotective Effect of Caffeine in Alzheimer’s Disease
Yelanchezian, Y. M. M., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2022) · Molecules · doi:10.3390/molecules27123737 · Cited by 75
Zhou, X., Li, Y., Shi, X., & Ma, C. (2016) · PubMed Central · Cited by 75
Caffeine Intake from Coffee or Tea and Cognitive Disorders: A Meta-Analysis of Observational Studies
Kim, Y.-S., Kwak, S. M., & Myung, S.-K. (2015) · Neuroepidemiology · doi:10.1159/000371710 · Cited by 66
Decaffeinated coffee prevents scopolamine-induced memory impairment in rats
Jang, Y. J., Kim, J., Shim, J., Kim, C., Jang, J.-H., Lee, K. W., & Lee, H. J. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.02.003 · Cited by 72
Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review
Chen, J. Q. A., Scheltens, P., Groot, C., & Ossenkoppele, R. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-201069 · Cited by 59
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
Flaten, V., Laurent, C., Coelho, J. E., Sandau, U. S., Batalha, V. L., Burnouf, S., Hamdane, M., Humez, S., Boison, D., Lopes, L. V., et al. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130229 · Cited by 66
Solfrizzi, V., and for the Italian Longitudinal Study on Aging Working Group 2, Panza, F., Imbimbo, B. P., D’Introno, A., Galluzzo, L., Gandin, C., Misciagna, G., Guerra, V., Osella, A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150333 · Cited by 65
Novel Players in the Aging Synapse: Impact on Cognition
Temido‐Ferreira, M., Coelho, J. E., Pousinha, P. A., & Lopes, L. V. (2019) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2019.0013 · Cited by 61
Liu, X., Du, X., Han, G., & Gao, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17429 · Cited by 60
Hu, Q., Ren, X., Liu, Y., Li, Z., Zhang, L., Chen, X., He, C., & Chen, J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.040 · Cited by 59
Zhao, Z., Zhao, Y., Ning, Y.-L., Yang, N., Peng, Y., Li, P., Chen, X.-Y., Liu, D., Wang, H., Chen, X., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.98 · Cited by 58
The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
Cellai, L., Carvalho, K., Faivre, É., Deleau, A., Vieau, D., Buée, L., Blum, D., Mériaux, C., & Gómez‐Murcia, V. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00520 · Cited by 58
Gardener, S. L., Rainey‐Smith, S. R., Villemagne, V. L., Fripp, J., Doré, V., Bourgeat, P., Taddei, K., Fowler, C. J., Masters, C. L., Maruff, P. T., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.744872 · Cited by 58
Lim, S., Mohaimin, S., Min, D., Roberts, T. R., Sohn, Y.-J., Wong, J., Sivanesathurai, R., Kwon, S. C., & Trinh‐Shevrin, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200509 · Cited by 57
Alzobaidi, N., Quasimi, H., Emad, N. A., Alhalmi, A., & Naqvi, M. (2021) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s299589 · Cited by 57
Driscoll, I., Shumaker, S. A., Snively, B. M., Margolis, K. L., Manson, J. E., Vitolins, M. Z., Rossom, R. C., & Espeland, M. A. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw078 · Cited by 55
Song, X., Singh, M. V., Lee, K. E., Vinayagam, R., & Kang, S. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212003 · Cited by 52
The Neuroprotective Effects of Moderate and Regular Caffeine Consumption in Alzheimer’s Disease
Zhou, X., & Zhang, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5568011 · Cited by 48
Zhu, Y., Hu, C.-X., Liu, X., Zhu, R., & Wang, B. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad089 · Cited by 46
Ghoneim, F. M., Khalaf, H. A., Elsamanoudy, A. Z., El‐khair, S. M. A., Helaly, A. M. N., Mahmoud, E.-H. M., & Elshafey, S. H. (2015) · PubMed Central · Cited by 45
Iranpour, S., Saadati, H. M., Koohi, F., & Sabour, S. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.09.003 · Cited by 43
Sugiyama, K., Tomata, Y., Kaiho, Y., Honkura, K., Sugawara, Y., & Tsuji, I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150693 · Cited by 41
Neuroprotective properties of coffee: An update
Carneiro, S. M., Oliveira, M. B. P. P., & Alves, R. C. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.04.052 · Cited by 40
Coffee consumption and incident dementia
Mirza, S. S., Tiemeier, H. W., de Bruijn, R. F. A. G., Hofman, A., Franco, O. H., Jong, J. C. K., Koudstaal, P. J., & Ikram, M. A. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9943-y · Cited by 39
Li, P., Rial, D., Canas, P. M., Jh, Y., Li, W., Zhou, X., Wang, Y., van Westen, G. J. P., Payen, M.-P., Augusto, E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.43 · Cited by 40
High coffee consumption, brain volume and risk of dementia and stroke
Pham, K., Mulugeta, A., Zhou, A., O'Brien, J. T., Llewellyn, D. J., & Hyppönen, E. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1945858 · Cited by 39
Caffeine Interaction with Glutamate Receptor Gene GRIN2A: Parkinson's Disease in Swedish Population
Yamada-Fowler, N., Fredrikson, M. G., & Söderkvist, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099294 · Cited by 39
Lin, Y.-S., Weibel, J., Landolt, H., Santini, F., Meyer, M., Brunmair, J., Meier, S. M., Gerner, C., Borgwardt, S., Cajochen, C., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab005 · Cited by 38
Li, S., Geiger, N. H., Soliman, M. L., Hui, L., Geiger, J. D., & Chen, X. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142223 · Cited by 35
Fisicaro, F., Lanza, G., Pennisi, M., Vagli, C., Cantone, M., Pennisi, G., Ferri, R., & Bella, R. (2021) · Nutrients · doi:10.3390/nu13020536 · Cited by 35
How Much Caffeine in Coffee Cup? Effects of Processing Operations, Extraction Methods and Variables
Severini, C., Derossi, A., Ricci, I., Fiore, A. G., & Caporizzi, R. (2017) · InTech eBooks · doi:10.5772/intechopen.69002 · Cited by 34
Merighi, S., Battistello, E., Casetta, I., Gragnaniello, D., Poloni, T. E., Medici, V., Cirrincione, A., Varani, K., Vincenzi, F., Borea, P. A., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201437 · Cited by 34
Association of Coffee Consumption with MRI Markers and Cognitive Function: A Population-Based Study
Araújo, L. F., Mirza, S. S., Bos, D., Niessen, W. J., Barreto, S. M., van der Lugt, A., Vernooij, M. W., Hofman, A., Tiemeier, H. W., & Ikram, M. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160116 · Cited by 34
Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?
Merighi, S., Poloni, T. E., Terrazzan, A., Moretti, E., Gessi, S., & Ferrari, D. (2021) · Cells · doi:10.3390/cells10051267 · Cited by 33
Acute Caffeine Administration Effect on Brain Activation Patterns in Mild Cognitive Impairment
Haller, S., Montandon, M., Rodriguez, C. K., Moser, D. A., Toma, S., Hofmeister, J., Sinanaj, I., Lövblad, K., & Giannakopoulos, P. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132360 · Cited by 35
The role of adenosine A2A receptors in Alzheimer's disease and tauopathies
Launay, A., Nebie, O., Shankara, J. V., Lebouvier, T., Buée, L., Faivre, É., & Blum, D. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109379 · Cited by 32
Nila, I. S., Moran, V. M. V., Khan, Z. A., & Hong, Y. (2023) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2023.13.2.83 · Cited by 31
Selected Micronutrients in Cognitive Decline Prevention and Therapy
Visioli, F., & Burgos‐Ramos, E. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9349-1 · Cited by 29
Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation
Soliman, M. L., Geiger, J. D., & Chen, X. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9707-4 · Cited by 28
Caffeine Consumption and Dementia: Are Lewy Bodies the Link?
Cornelis, M. C., Bennett, D. A., Weıntraub, S., Schneider, J. A., & Morris, M. C. (2022) · Annals of Neurology · doi:10.1002/ana.26349 · Cited by 27
Zhu, Y., Park, S., Kolady, R., Zha, W., Ma, Y., Dias, A., McGuire, K., Hardi, A., Lin, S. C., Ismail, Z., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13820 · Cited by 26
Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?
Schreiner, T. G., & Popescu, B. O. (2022) · Life · doi:10.3390/life12030330 · Cited by 26
Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer’s Disease
Zhang, X., Lao, K., Qiu, Z., Rahman, M. S., Zhang, Y., & Gou, X. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181084 · Cited by 25
Fisicaro, F., Lanza, G., Pennisi, M., Vagli, C., Cantone, M., Falzone, L., Pennisi, G., Ferri, R., & Bella, R. (2022) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2022.2050999 · Cited by 24
West, R. K., Ravona‐Springer, R., Livny, A., Heymann, A. D., Shahar, D. R., LeRoith, D., Preiss, R., Zukran, R., Silverman, J. M., & Beeri, M. S. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly090 · Cited by 24
Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer';s Disease
Dominguez, L. J., & Barbagallo, M. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151204000733 · Cited by 23
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
Merighi, S., Poloni, T. E., Pelloni, L., Pasquini, S., Varani, K., Vincenzi, F., Borea, P. A., & Gessi, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.652455 · Cited by 20
No Effects of Black Tea on Cognitive Decline Among Older US Men: A Prospective Cohort Study
Feng, L., Osteoporotic Fractures in Men (MrOS) Study Group, Langsetmo, L., Yaffe, K. S., Sun, Y., Fink, H. A., Shikany, J. M., Leung, P., Lane, N. E., & Cauley, J. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180103 · Cited by 17
Abbel, D., Åsvold, B. O., Kolberg, M., Selbæk, G., Noordam, R., & Skjellegrind, H. K. (2023) · Nutrients · doi:10.3390/nu15112469 · Cited by 17
Coffee aroma constituents and odorant metabolites in human urine
Wagenstaller, M., & Buettner, A. (2013) · Metabolomics · doi:10.1007/s11306-013-0581-2 · Cited by 15
Wang, B., Ma, T., Yang, L., He, S., Li, J., & Sun, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-71426-y · Cited by 14
Cognitive recovery in patients with post-stroke subjective cognitive complaints
Ji, S., Sun, H., Jin, X., Chen, B., Zhou, J., Zhao, J., Liang, X., Shen, W., Zhang, Y., & Chan, P. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.977641 · Cited by 14
Lopes, C. R., Silva, A. C., Silva, H. B. L., Canas, P. M., Agostinho, P. M., Cunha, R. A., & Lopes, J. P. (2023) · Biomolecules · doi:10.3390/biom13081173 · Cited by 13
Bae, J. (2020) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2020.19.3.108 · Cited by 13
Association of coffee and genetic risk with incident dementia in middle-aged and elderly adults
Zhang, Y., Yang, H., Li, S., Cao, Z., Li, W., Yan, T., & Wang, Y. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1966868 · Cited by 13
Green coffee as a novel agent for Alzheimer’s disease prevention by attenuating diabetes
Varghese, M., Ho, L., Wang, J., Zhao, W., Levine, S., Ono, K., Mannino, S., & Pasinetti, G. M. (2014) · Translational Neuroscience · doi:10.2478/s13380-014-0213-y · Cited by 12
Arosio, B., Casati, M., Gussago, C., Ferri, E., Abbate, C., Scortichini, V., Colombo, E. V., Rossi, P. D., & Mari, D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160324 · Cited by 12
Nerurkar, P. V., Yokoyama, J., Ichimura, K., Kutscher, S., Wong, J., Bittenbender, H. C., & Deng, Y. (2023) · Metabolites · doi:10.3390/metabo13030412 · Cited by 11
Estilo de vida y riesgo de padecer demencia
Menéndez‐González, M., Fernández, B. S., & Lopez-Muniz, A. (2011) · Archivos de Medicina · Cited by 11
The adenosine A2A receptor is a therapeutic target in neurological, heart and oncogenic diseases
Franco, R., Lillo, A., Navarro, G., & Reyes‐Resina, I. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2136570 · Cited by 9
The role of lifestyle factors in primary prevention of dementia: an epidemiological perspective
Deckers (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170511kd · Cited by 9
Dementia Research: Populations, Progress, Problems, and Predictions
Hunter, S., Smailagic, N., & Brayne, C. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179927 · Cited by 7
The effects of midlife diet on late-life cognition : an epidemiological approach
Eskelinen, M. H. (2014) · UEF eRepo (University of Eastern Finland) · Cited by 7
Metadata
- Authors
- Gelber, R. P., Petrovitch, H., Masaki, K. H., Ross, G. W., & White, L. R.
- Affiliations
- University of Hawaiʻi at Mānoa (US)
- Corresponding author
- Gelber, Rebecca P.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2011-03-21
- Volume
- 23
- Issue
- 4
- Pages
- 607-615
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC3731132
- OpenAlex
- W2161647071
- Cited by
- 133
- References
- 31
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 9 · 2023: 10 · 2022: 9 · 2021: 17 · 2020: 8 · 2019: 6 · 2018: 11 · 2017: 10 · 2016: 14 · 2015: 9 · 2014: 14 · 2013: 7 · 2012: 4
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-08-05)
- Open access
- green
- europepmc.org
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u01ag019349-08, 5u01ag017155-10)
- National Institute on Aging (U01-AG017155, 3U01 AG017155-09S1, 5U01AG017155‐09, 5U01 AG19349-09, U01-AG019349)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- coffee consumption, caffeine
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Alzheimer Disease, Asian, Brain, Caffeine, Coffee, Cognition Disorders, Dementia, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Tea, Dementia, Vascular, Cohort Studies, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.